A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

NCT02057484 · clinicaltrials.gov ↗

COMPLETED

Status

2300

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplant
Kidney Transplant

Interventions

DRUG: Tacrolimus

Sponsor

Astellas Pharma Europe Ltd.